Since its founding, the Castleman Disease Collaborative Network (CDCN) has worked to identify an effective treatment for Castleman disease, a rare immune system disorder that leads to a cytokine storm and multi-organ failure—much like what’s being seen in COVID-19 patients. Here to review how the CDCN’s innovations are now being leveraged toward the fight against COVID-19 is the CDCN’s Co-Founder and Executive Director Dr. David Fajgenbaum.
NIH Study Identifies Cause for Long COVID Neurological Symptoms
The Role of Antivirals in COVID-19 Rebound Infections
Tackling the Tripledemic: A Look at Combatting COVID-19, RSV, & the Flu
COVID-19: Differentiating Disease Course and Updates on Treatment
COVID-19: Updates on Best Practices to Improve Outcomes
Post COVID-19 Psychological Distress: A Review of Risk Factors & Patient Burden
The New COVID-19 Booster: Updates & Changes You Need to Know
Exploring the Impacts of the Pandemic on Medical Students
Examining the Employment Effect of COVID-19 in the Healthcare Field
Boosting Immunity Amid a Pandemic: The Role of Behaviors, Diet, & Environment
Diving Into Dysphonia & Vocal Fatigue: A Conversation on Voice Problems Amid COVID-19
COVID-19 & Pregnancy: What Do We Need To Know?
Post-COVID Care: How One Clinic Is Treating Long Haulers
Coexisting with COVID-19: A Look Ahead
Breaking Down Barriers to COVID-19 Vaccine Access
Applying mRNA Vaccine Technology to HIV/AIDS
Preventing the Next Pandemic: The Potential Role of Antibodies
Strategies for Combating COVID-19 Conspiracies & Myths
Using Machine Learning to Fight Future Pandemics
Dealing with Delta: Insights from ICUs Across the Country
Create your
podcast in
minutes
It is Free
RenaissanceOnlineRadio.com
Men in Lead Aprons
Denver Underground
Exercise: Learn To Love (Or At Least Like) It
NASACast Video